A 2023 indictment unsealed this week alleges that two men were directed by China's spy agency to target and access the emails of virologists and immunologists at two Houston-area universities.

The full approval of Spikevax covers children aged six months through 11 years who are at increased risk for severe COVID-19, transitioning the vaccine from emergency use to full licensure.

The US Food and Drug Administration granted full approval to Moderna's Spikevax vaccine and the company is hopeful of releasing the updated version for the 2025-26 flu season ...